STAT4 and the proliferation of artery smooth muscle cells in atherosclerosis

Experimental and Molecular Pathology

Volumn 81, Issue 1, 2006, Pages 15-22

  Guo, Feng ^a   Zarella, Christopher ^a   Wagner, William D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; IL 12; Smooth muscle cells; STAT4

Indexed keywords

INTERLEUKIN 12; STAT4 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROGENESIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE PREDISPOSITION; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE TARGETING; IMMUNOSTIMULATION; NONHUMAN; PIGEON; PROTEIN EXPRESSION; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPECIES COMPARISON; TRANSCRIPTION INITIATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; CELL PROLIFERATION; COLUMBIDAE; GENE EXPRESSION REGULATION; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; STAT4 TRANSCRIPTION FACTOR; UP-REGULATION;

COLUBER CONSTRICTOR; COLUMBA;

EID: 33745411611     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.04.009     Document Type: Article

References (41)

1. Amiri F., Venema V.J., Wang X., Ju H., Venema R.C., and Marrero M.B. Hyperglycemia enhances angiotensin II-induced Janus-activated kinase/STAT signaling in vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 32382-32386
2. Bacon C.M., Petricoin III E.F., Ortaldo J.R., Rees R.C., Larner A.C., Johnston J.A., and O'Shea J.J. Interleukin 12 induces tyrosine phosphorylation and activation of Stat4 in human lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7307-7311
3. Baetta R., Soma M., De-Fraja C., Comparato C., Teruzzi C., Magrassi L., and Cattaneo E. Upregulation and activation of stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 931-939
4. Banskota N.K., Taub R., Zellner K., Olsen P., and King G.L. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38 (1989) 123-129
5. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., and Weissberg P.L. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ. Res. 82 (1998) 704-712
6. Chang M.W., Barr E., Lu M.M., Barton K., and Leiden J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96 (1995) 2260-2268
7. Clarkson T.B., Pritchard R.W., Netsky M.G., and Lofland H.B. Atherosclerosis in pigeons: its spontaneous occurrence and resemblance to human atherosclerosis. AMA Arch. Pathol. 68 (1959) 143-147
8. Clowes A., and Schwartz S. Significance of quiescent smooth muscle migration in injured rat carotic artery. Circ. Res. 56 (1985) 139-145
9. de Nigris F., Youssef T., Ciafre S., Franconi F., Anania V., Condorelli G., Palinski W., and Napoli C. Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMCs and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation 02 (2000) 2111-2117
10. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
11. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
12. Dumler I., Kopmann A., Wagner K., Mayboroda O.A., Jerke U., Dietz R., Haller H., and Gulba D.C. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 24059-24065
13. Edwards I.J., and Wagner W.D. Cell surface heparan sulfate proteoglycan and chondroitin sulfate proteoglycan of arterial smooth muscle cells. Am. J. Pathol. 140 (1992) 193-205
14. Govindarajan B., Bai X., Cohen C., Zhong H., Kilroy S., Louis G., Moses M., and Arbiser J.L. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J. Biol. Chem. 278 (2003) 9790-9795
15. Horvath C.M., and Darnell J.E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9 (1997) 233-239
16. Ihle J.N. Signal transducers and activators of transcription. Cell 84 (1996) 331-334
17. Ivanov V.O., Rabovsky A.B., Ivanova S.V., and Niedzwiecki A. Transforming growth factor-beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms. Atherosclerosis 140 (1998) 25-34
18. Jacobson N.G., Szabo S.J., Weber-Nordt R.M., Zhong Z., Schreiber R.D., Darnell Jr. J.E., and Murphy K.M. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and Stat4. J. Exp. Med. 181 (1995) 1755-1762
19. Jerome W.G., and Lewis J.C. Early atherogenesis in White Carneau pigeons: II. Ultrastructural and cytochemical observations. Am. J. Pathol. 119 (1985) 210-222
20. Jerome W.G., and Lewis J.C. Cellular dynamics in early atherosclerotic lesion progression in White Carneau pigeons. Spatial and temporal analysis of monocyte and smooth muscle invasion of the intima. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 654-664
21. Kaplan M.H., Sun Y.L., Hoey T., and Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382 (1996) 174-177
22. Kindy M., and Sonenshein G. Regulation of oncogene expression in cultured aortic smooth muscle cells: post-transcriptional control of c-myc mRNA. J. Biol. Chem. 261 (1986) 12865-12868
23. Lee T.S., Yen H.C., Pan C.C., and Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 734-742
24. Pauly R.R., Bilato C., Cheng L., Monticone R., and Crow M.T. Vascular smooth cell cultures. Methods Cell Biol. 52 (1998) 133-153 (Chapter 7)
25. Pukac L., Castellot J., Wright T., Caleb B., and Karnovsky M. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul. 1 (1990) 435-443
26. Rivard A., Principe N., and Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging. SMC proliferation and atherosclerosis. Cardiovasc. Res. 45 (2000) 1026-1034
27. Santerre R.F., Weight T.N., Smith S.C., and Brannigan D. Spontaneous atherosclerosis in pigeons: a model system for studying metabolic parameters associated with atherogenesis. Am. J. Pathol. 67 (1972) 1-22
28. Schindler C., and Darnell Jr. J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann. Rev. Biochem. 64 (1995) 621-651
29. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding protein with "mini-extracts", prepared from a small number of cells. Nucleic Acid Res. 17 (1989) 6419
30. Seder R.A., Kelsall B.L., and Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157 (1996) 2745-2748
31. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A., Doherty P.C., Grosveld G.C., and Ihle J.N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382 (1996) 171-174
32. Trembleau S., Germann T., Gately M.K., and Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16 (1995) 383-386
33. Ueno H., Yamamoto H., Ito S., Li J.J., and Takeshita A. Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 898-904
34. Usuda J., Chiu S., Murphy E.S., Lam M., Nieminen A.L., and Oleinick N.L. Domain-dependent photodamage to Bcl-2 a membrane anchorage region is needed to form the target of phthalocyanine photosensitization. J. Biol. Chem. 278 (2003) 2021-2029
35. Uyemura K., Demer L.L., Castle S.C., Jullien D., Berliner J.A., Gately M.K., Warrier R.R., Pham N., Fogelman A.M., and Modlin R.L. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97 (1996) 2130-2138
36. Wheeler M.D., Smutney O.M., Check J.F., Rusyn I., Schulte-Hermann R., and Thurman R.G. Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am. J. Physiol.: Gasterointest. Liver Physiol. 284 (2003) G302-G312
37. Yamamoto K., Kobayashi H., Arai A., Miura O., Hirosawa S., and Miyasaka N. cDNA cloning, expression and chromosome mapping of the human STAT4 gene: both STAT4 and STAT1 genes are mapped to 2q32.2→q32.3. Cytogenet. Cell Genet. 77 (1997) 207-210
38. Yang Z.Y., Simari R.D., Perkins N.D., San H., Gordon D., Nabel G.J., and Nabel E.G. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7905-7910
39. Yang Z.H., Kitami Y., Takata Y., Okura T., and Hiwada K. Targeted overexpression of CCAAT/enhancer-binding protein-δ evokes enhanced gene transcription of platelet-derived growth factor α-receptor in vascular smooth muscle cells. Circ. Res. 89 (2001) 503-508
40. Yu C.R., Lin J.X., Fink D.W., Akira S., Bloom E.T., and Yamauchi A. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J. Immunol. 157 (1996) 126-137
41. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4806-4810